Chinese newspaper coverage of (unproven) stem cell therapies and their providers

Stem Cell Rev Rep. 2013 Apr;9(2):111-8. doi: 10.1007/s12015-012-9425-0.

Abstract

China is a primary destination for stem cell tourism, the phenomenon whereby patients travel abroad to receive unproven stem cell-based treatments that have not been approved in their home countries. Yet, much remains unknown about the state of the stem cell treatment industry in China and about how the Chinese view treatments and providers. Given the media's crucial role in science/health communication and in framing public dialogue, this study sought to examine Chinese newspaper portrayal and perceptions of stem cell treatments and their providers. Based on a content analysis of over 300 newspaper articles, the study revealed that while Chinese newspaper reporting is generally neutral in tone, it is also inaccurate, overly positive, heavily influenced by "interested" treatment providers and focused on the therapeutic uses of stem cells to address the health needs of the local population. The study findings suggest a need to counterbalance providers' influence on media reporting through strategies that encourage media uptake of accurate information about stem cell research and treatments.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bibliometrics
  • China
  • Humans
  • Medical Tourism
  • Newspapers as Topic / ethics*
  • Newspapers as Topic / standards
  • Public Opinion
  • Publication Bias / statistics & numerical data*
  • Stem Cell Transplantation / ethics*
  • Stem Cell Transplantation / standards